Portland, OR, United States of America

Martin J Kelly

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Oregon Health & Science University, University of California. Active years: 2007-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin J Kelly. Retrieved from https://idiyas.com/inventor/martin-j-kelly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Martin J Kelly: Innovator in Selective Estrogen Receptor Modulators

Introduction

Martin J Kelly is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of pharmacology, particularly in the development of selective estrogen receptor modulators (SERMs). With a total of 2 patents, his work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Kelly's latest patents focus on the development of a new class of selective estrogen receptor modulators. The present disclosure concerns a new class of SERMs, which includes the identification of a previously unknown membrane-associated estrogen receptor. The patents also detail methods for making and using these SERMs, including pharmaceutical formulations of the novel compounds in useful compositions.

Career Highlights

Throughout his career, Martin J Kelly has worked with esteemed institutions such as the University of California and Oregon Health & Science University. His research has been pivotal in advancing the understanding of estrogen receptors and their modulators.

Collaborations

Some of his notable coworkers include Thomas S Scanlan and Jian Qiu. Their collaborative efforts have contributed to the innovative research in the field of selective estrogen receptor modulation.

Conclusion

Martin J Kelly's work in the development of selective estrogen receptor modulators showcases his dedication to advancing medical science. His contributions are expected to have lasting effects on therapeutic strategies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…